Nephrological treatment of severe heart failure

被引：0
|
作者：
Schwenger, V. [1 ]
Remppis, B. A. [2 ]
机构：
[1] Klinikum Stuttgart, Transplantat Zentrum Stuttgart, Klin Nieren Hochdruck & Autoimmunerkrankungen, Katharinenhosp Stuttgart, Haus 1,Kriegsbergstr 60, D-70174 Stuttgart, Germany
[2] Herz & Gefasszentrum, Klin Kardiol, Bad Bevensen, Germany
来源：
NEPHROLOGE | 2018年 / 13卷 / 02期
关键词：
Cardio-renal syndrome; Congestive heart failure; Renal insufficiency; Ultrafiltration; Interdisciplinary therapy;
D O I：
10.1007/s11560-017-0223-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic heart failure is not only one of the fastest growing morbidities in western countries but also one of the commonest reasons for hospitalization. Up to 50-60% of heart failure patients suffer from renal failure, which is often the reason for hospitalization. In patients with cardio-renal syndrome renal failure is one of the strongest predictors for mortality. Due to the close pathophysiological and prognostic interactions between these two organs, patients with cardio-renal syndrome should receive interdisciplinary, patient and symptom-oriented treatment in collaboration with cardiologists and nephrologists.
引用
收藏
页码：104 / 110
页数：7
相关论文
共 50 条
  • [1] Ultrafiltration in the treatment of severe congestive heart failure
    Eirini Grapsa
    George P. Alexopoulos
    Zafeiria Margari
    John V. Terrovitis
    Dimitrios A. Kontoyannis
    John N. Nanas
    [J]. International Urology and Nephrology, 2004, 36 : 269 - 272
  • [2] Ultrafiltration in the treatment of severe congestive heart failure
    Grapsa, Eirini
    Alexopoulos, George P.
    Margari, Zafeiria
    Terrovitis, John V.
    Kontoyannis, Dimitrios A.
    Nanas, John N.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2004, 36 (02) : 269 - 272
  • [3] Pacemaker resynchronisation in the treatment of severe heart failure
    Atlee, J. L.
    [J]. ANAESTHESIA, PAIN, INTENSIVE CARE AND EMERGENCY MEDICINE, 2005, : 99 - 112
  • [4] Correction of anemia in the treatment of severe heart failure
    Pérez-Villa, F
    [J]. MEDICINA CLINICA, 2005, 124 (04): : 158 - 158
  • [5] A new treatment option for severe heart failure
    Myers, JA
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 163 (07) : 877 - 877
  • [6] CATECHOLAMINES FOR TREATMENT OF SEVERE HEART-FAILURE
    MAURER, W
    TILLMANNS, H
    KUBLER, W
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1979, 68 (05): : 290 - 297
  • [7] TREATMENT OF SEVERE ACUTE HEART-FAILURE
    URBAN, P
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 120 (49) : 1838 - 1844
  • [8] THE OUTCOME OF TREATMENT IN PATIENTS WITH SEVERE HEART-FAILURE
    BARLOW, J
    BELLACI, HF
    BURKE, EJ
    DAHLSTROM, U
    DICKSTEIN, K
    FITZGERALD, DJ
    FRANK, J
    GAZES, PC
    KIRCHERTZ, EJ
    OAKLEY, CM
    PACKER, M
    SHAPIRO, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 : S237 - S239
  • [9] PHENTOLAMINE FOR VASODILATOR TREATMENT OF SEVERE HEART-FAILURE
    PERRET, C
    POLI, S
    ENRICO, JF
    [J]. LANCET, 1971, 2 (7731): : 978 - &
  • [10] CAPD IN THE TREATMENT OF SEVERE CONGESTIVE HEART-FAILURE
    PAGE, D
    HIERLIHY, PJ
    COUTURE, RA
    LEVINE, DZ
    [J]. PERITONEAL DIALYSIS BULLETIN, 1984, 4 (01): : 56 - 57
12345